Osteoarthritis year in review 2021

mechanics

Review (2022)
Authors

Jaap Harlaar (Erasmus MC, TU Delft - Biomechatronics & Human-Machine Control)

E.M. Macri (Erasmus MC)

M.G.H. Wesseling (TU Delft - Biomechatronics & Human-Machine Control)

Research Group
Biomechatronics & Human-Machine Control
Copyright
© 2022 J. Harlaar, E.M. Macri, M.G.H. Wesseling
To reference this document use:
https://doi.org/10.1016/j.joca.2021.12.012
More Info
expand_more
Publication Year
2022
Language
English
Copyright
© 2022 J. Harlaar, E.M. Macri, M.G.H. Wesseling
Research Group
Biomechatronics & Human-Machine Control
Issue number
5
Volume number
30
Pages (from-to)
663-670
DOI:
https://doi.org/10.1016/j.joca.2021.12.012
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Osteoarthritis (OA) has a complex, heterogeneous and only partly understood etiology. There is a definite role of joint cartilage pathomechanics in originating and progressing of the disease. Although it is still not identified precisely enough to design or select targeted treatments, the progress of this year's research demonstrates that this goal became much closer. On multiple scales - tissue, joint and whole body - an increasing number of studies were done, with impressive results. (1) Technology based instrument innovations, especially when combined with machine learning models, have broadened the applicability of biomechanics. (2) Combinations with imaging make biomechanics much more precise & personalized. (3) The combination of Musculoskeletal & Finite Element Models yield valid personalized cartilage loads. (4) Mechanical outcomes are becoming increasingly meaningful to inform and evaluate treatments, including predictive power from biomechanical models. Since most recent advancements in the field of biomechanics in OA are at the level of a proof op principle, future research should not only continue on this successful path of innovation, but also aim to develop clinical workflows that would facilitate including precision biomechanics in large scale studies. Eventually this will yield clinical tools for decision making and a rationale for new therapies in OA.